Uses, Side Effects, Dosage, and FAQs (2026 Guide)
Ozempic (semaglutide) is a once-weekly prescription injection used in adults with type 2 diabetes. It is FDA-approved to improve blood sugar control (along with diet and exercise) and to reduce the risk of major cardiovascular events, like heart attack or stroke, in adults who have both type 2 diabetes and known heart disease.
Ozempic is a GLP-1 agonist, which works by mimicking a natural hormone in your body. This action helps the pancreas release insulin, stops the liver from making too much sugar, and slows down digestion. This slowing of digestion is what causes the most common side effects, such as nausea, vomiting, and diarrhea, especially when starting the medication. It’s also why the drug often leads to reduced appetite and weight loss, a common off-label use.
Ozempic belongs to a class of drugs called GLP-1 receptor agonists (or “incretin mimetics”). It works by copying the actions of a natural hormone in your body called glucagon-like peptide-1 (GLP-1).
When you eat, your body releases GLP-1. Ozempic mimics this hormone to:
This combination of effects helps lower your blood sugar after meals, control your A1c, and often makes you feel fuller longer, which can reduce your appetite.
| Quick Facts | |
|---|---|
| Common Brands | Ozempic |
| Drug Class | GLP-1 agonist |
| Generic Status | No generic available |
| Availability | Prescription Only |
Ozempic is a once-weekly subcutaneous (under the skin) injection. The dose is “titrated,” meaning it starts low and slowly increases to help your body adjust and to minimize gastrointestinal side effects.
Note: Dosing information is educational only. Your prescribing physician will determine your specific dose based on your individual health needs. Always follow your healthcare provider’s instructions for exact dosing.
FDA-Approved Uses
Off-Label Uses
You may see Ozempic prescribed for uses that are not “FDA-approved.” This is a very common and legal practice called “off-label” prescribing, where a doctor uses their clinical judgment to prescribe a drug for a different (but well-researched) purpose.
Ozempic is very commonly prescribed “off-label” for weight loss. Its active ingredient, semaglutide, is FDA-approved for this specific use under the brand name Wegovy.
Join our mailing list for exclusive deals and more.
Common Side Effects
The most common side effects are gastrointestinal and are most likely to happen when you first start the medicine or after a dose increase.
Serious Side Effects
Serious side effects are rare, but it’s important to know what to look for if they do occur.
Call your doctor immediately if you experience any concerning or prolonged symptoms.
Store your new, unused Ozempic pens in the refrigerator. After you use a pen for the first time, you can store it in the refrigerator or at room temperature (below 86°F) for up to 56 days (8 weeks).
If you miss a dose, take it as soon as you remember, as long as it’s within 5 days of the missed dose. If more than 5 days have passed, it is recommended to skip the missed dose and take your next dose on your regular scheduled day.
If you need to, you can change the day of the week you take your injection, as long as there are at least 2 days (48 hours) between your doses.
Inject Ozempic under the skin of your stomach (abdomen), thigh, or upper arm. Be sure to rotate your injection site each week.
Nausea, vomiting, and diarrhea can cause dehydration. It’s very important to drink plenty of fluids to stay hydrated and help protect your kidneys.
Ozempic may harm an unborn baby. You should stop using it at least 2 months before you plan to become pregnant.
Do not share your Ozempic pen with anyone else, even if you change the needle. This can lead to infection.
Two important interactions to be aware of are:
Always give your doctor and pharmacist a complete list of all your medications, vitamins, and supplements to check for potential interactions.
No, Ozempic is not insulin. It is a GLP-1 agonist that helps your body release its own insulin when your blood sugar is high. It will not work for people with type 1 diabetes.
They are the exact same active ingredient (semaglutide). Ozempic is FDA-approved and dosed for type 2 diabetes (up to 2 mg). Wegovy is FDA-approved and dosed for chronic weight management (up to 2.4 mg).
Both are once-weekly injections for type 2 diabetes, but they work slightly differently. Ozempic is a single-action GLP-1 agonist. Mounjaro (tirzepatide) is a dual-action agonist, targeting both GLP-1 and GIP receptors.
You may start to see a change in your blood sugar levels within the first week, but the full effect can take 8 weeks or longer as your dose is gradually increased. For weight management, it varies greatly from person to person.
You should be cautious. Alcohol itself can affect your blood sugar (both raising it and lowering it). It can also increase the risk of side effects like nausea or pancreatitis. It’s best to talk to your doctor about alcohol consumption on Ozempic.
It depends on the pen and your prescribed dose. For example, a “red” pen that delivers 0.5 mg doses contains four 0.5 mg doses. A “blue” pen that delivers 1 mg doses contains four 1 mg doses. Your pen should be discarded 56 days after the first use, even if there is medicine left.
There is no “best” site, but you can inject it into your stomach (abdomen), thigh, or upper arm. Many people find the stomach is the easiest. The most important thing is to rotate your injection site each week to avoid skin irritation.
Once a pen is used for the first time, it can be safely stored at room temperature (below 86°F) or in the refrigerator for up to 56 days. Do not use a pen that has been left out for more than 56 days and never use a pen that has been frozen.
Ozempic is one of several popular incretin-mimetic drugs.
The same once-weekly dual-action (GIP/GLP-1) drug as Mounjaro, but branded for Chronic Weight Management.
The only oral pill version of semaglutide, taken daily and approved for Type 2 Diabetes.
The same once-weekly single-action (GLP-1) drug as Ozempic, but branded for Chronic Weight Management.
A once-daily single-action (GLP-1) injection approved for Type 2 Diabetes, sold at a significantly lower cost than other GLP-1s.
Important: Information on this page is for educational purposes only. Prescribing decisions are made by independent, licensed providers. TelyRx operates technology-enabled pharmacies and a telehealth platform that connects patients with board-certified licensed providers. Prescriptions, when provider-approved and issued, are filled and shipped by TelyRx-affiliated pharmacies. We do not employ physicians or make prescribing decisions. Learn more about our editorial standards here.
